Methusalem Podcast

Methusalem Podcast with Niklas Anzinger

41 min · 23. helmi 2026
jakson Methusalem Podcast with Niklas Anzinger kansikuva

Kuvaus

In this episode of the Methusalem Podcast, I discuss with Niklas Anzinger, founder and CEO of Infinita City, the story behind Próspera, a special economic zone on the island of Roatán, Honduras. Niklas shares his journey from public policy and the Berlin startup scene to building a jurisdiction designed to accelerate biotech and longevity innovation. We cover how Próspera operates as a startup city with its own regulatory framework, why Niklas believes FDA-style regulatory monopolies are the biggest bottleneck in longevity research rather than the science itself, and how Próspera's insurance-based regulatory model offers a market-driven alternative. We also discuss biotech companies already operating on-site. If you're a founder or researcher interested in launching a biotech company in this unique regulatory environment, check out the BioHub Startup Accelerator at luma.com/BioHub2026 [https://luma.com/BioHub2026]. For more information on Infinita City and everything happening at Prospera, visit the homepage at infinita.city [https://www.infinita.city/].

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity Methusalem Podcast-yhteisöön!

Aloita nyt

3 kuukautta hintaan 3,99 €

Sitten 7,99 € / kuukausi · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

5 jaksot

jakson Methusalem Podcast with Niklas Anzinger kansikuva

Methusalem Podcast with Niklas Anzinger

In this episode of the Methusalem Podcast, I discuss with Niklas Anzinger, founder and CEO of Infinita City, the story behind Próspera, a special economic zone on the island of Roatán, Honduras. Niklas shares his journey from public policy and the Berlin startup scene to building a jurisdiction designed to accelerate biotech and longevity innovation. We cover how Próspera operates as a startup city with its own regulatory framework, why Niklas believes FDA-style regulatory monopolies are the biggest bottleneck in longevity research rather than the science itself, and how Próspera's insurance-based regulatory model offers a market-driven alternative. We also discuss biotech companies already operating on-site. If you're a founder or researcher interested in launching a biotech company in this unique regulatory environment, check out the BioHub Startup Accelerator at luma.com/BioHub2026 [https://luma.com/BioHub2026]. For more information on Infinita City and everything happening at Prospera, visit the homepage at infinita.city [https://www.infinita.city/].

23. helmi 202641 min